Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Metagenomi Inc (MGX)

Metagenomi Inc (MGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 82,612
  • Shares Outstanding, K 37,381
  • Annual Sales, $ 52,300 K
  • Annual Income, $ -78,060 K
  • EBIT $ -88 M
  • EBITDA $ -90 M
  • 60-Month Beta -0.38
  • Price/Sales 1.67
  • Price/Cash Flow N/A
  • Price/Book 0.41

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.68
  • Number of Estimates 3
  • High Estimate -0.54
  • Low Estimate -0.79
  • Prior Year -0.29
  • Growth Rate Est. (year over year) -134.48%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.39 +54.91%
on 06/16/25
2.47 -12.82%
on 07/09/25
+0.66 (+44.52%)
since 06/11/25
3-Month
1.39 +54.91%
on 06/16/25
2.47 -12.82%
on 07/09/25
+0.67 (+45.49%)
since 04/11/25
52-Week
1.23 +75.07%
on 04/04/25
5.50 -60.85%
on 07/12/24
-2.49 (-53.59%)
since 07/11/24

Most Recent Stories

More News
Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025

MGX : 2.16 (-2.26%)
Metagenomi: Q1 Earnings Snapshot

Metagenomi: Q1 Earnings Snapshot

MGX : 2.16 (-2.26%)
Metagenomi Reports Business Updates and First Quarter 2025 Financial Results

MGX : 2.16 (-2.26%)
Metagenomi to Present at Upcoming Scientific Meetings

MGX : 2.16 (-2.26%)
Metagenomi Reports Business Updates and Full Year 2024 Financial Results

MGX : 2.16 (-2.26%)
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week

Positive data from clinical trials, earnings readouts, M&A speculation and new research drew heavy interest from retail traders on Stocktwits for these tickers for the week ended March 14, 2025.

TNYA : 0.6876 (-0.03%)
CSCI : 3.53 (+0.57%)
MLYS : 14.77 (+0.89%)
SWTX : 46.99 (+0.02%)
MGX : 2.16 (-2.26%)
Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems

MGX : 2.16 (-2.26%)
Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference

MGX : 2.16 (-2.26%)
Stargate, Netflix, GE Aerospace, Twilio, and More

There's a lot for investors to talk about.

NFLX : 1,243.85 (-0.54%)
META : 718.41 (-1.21%)
GOOGL : 181.32 (+2.08%)
NVDA : 165.62 (+0.93%)
GOOG : 182.52 (+2.14%)
TWLO : 113.65 (-3.13%)
ATEN : 18.43 (-2.64%)
F : 11.82 (-0.76%)
JPM : 286.76 (-0.50%)
RKLB : 39.59 (+1.25%)
NKE : 72.64 (-2.65%)
ORCL : 231.37 (-1.54%)
Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones

MGX : 2.16 (-2.26%)

Business Summary

Metagenomi Inc. is a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived gene editing toolbox. Metagenomi Inc. is based in EMERYVILLE, Calif.

See More

Key Turning Points

3rd Resistance Point 2.55
2nd Resistance Point 2.48
1st Resistance Point 2.34
Last Price 2.16
1st Support Level 2.13
2nd Support Level 2.06
3rd Support Level 1.92

See More

52-Week High 5.50
Fibonacci 61.8% 3.87
Fibonacci 50% 3.36
Fibonacci 38.2% 2.86
Last Price 2.16
52-Week Low 1.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar